Patent Assignment
Reel/Frame 017685/0323
Assignment of Assignor's Interest
Recorded: 2006-05-26
Pages: 7
Assignors
MCLACHLAN, KAREN
Executed: 2006-03-15
REFF, MITCHELL
Executed: 2006-04-19
DANIELS, MARK
Executed: 2006-03-15
Assignee
BIOGEN IDEC INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(6)
Genes Overexpressd by Ovarian Cancer and Their Use in Developing Novel Therapeuctics, Especially Antibodies
PCT:
PCT/US2002/040861 ↗
Genes correlated to ovarian cancer and their use in developing novel therapeutics
Application:
60/341,860 →
Genes correlated to ovarian cancer and their use in developing novel therapeutics
Application:
60/386,748 →
Genes correlated to ovarian cancer and their use in developing novel therapeutics
Application:
60/396,141 →
Genes correlated to ovarian cancer and their use in developing novel therapeutics
Application:
60/405,319 →
Genes correlated to ovarian cancer and their use in developing novel therapeutics
Application:
60/428,274 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Aug 6, 2004
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 015044/0873 →
Change of Name
Dec 28, 2004
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 015502/0150 →
Assignment of Assignor's Interest
May 26, 2006
From: BIOGEN IDEC INC.
To: BIOGEN IDEC MA INC.
Reel/Frame 017685/0341 →